205 related articles for article (PubMed ID: 36463288)
41. BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells.
Litzenburger BC; Kim HJ; Kuiatse I; Carboni JM; Attar RM; Gottardis MM; Fairchild CR; Lee AV
Clin Cancer Res; 2009 Jan; 15(1):226-37. PubMed ID: 19118050
[TBL] [Abstract][Full Text] [Related]
42. Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer.
Abdalla AN; Qattan A; Malki WH; Shahid I; Hossain MA; Ahmed M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050377
[TBL] [Abstract][Full Text] [Related]
43. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
[TBL] [Abstract][Full Text] [Related]
44. Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.
Bailey ST; Westerling T; Brown M
Cancer Res; 2015 Jan; 75(2):436-45. PubMed ID: 25388283
[TBL] [Abstract][Full Text] [Related]
45. Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: role of β-catenin/connexin43 association.
Talhouk RS; Fares MB; Rahme GJ; Hariri HH; Rayess T; Dbouk HA; Bazzoun D; Al-Labban D; El-Sabban ME
Exp Cell Res; 2013 Dec; 319(20):3065-80. PubMed ID: 24120736
[TBL] [Abstract][Full Text] [Related]
46. (-)‑Oleocanthal inhibits proliferation and migration by modulating Ca
Diez-Bello R; Jardin I; Lopez JJ; El Haouari M; Ortega-Vidal J; Altarejos J; Salido GM; Salido S; Rosado JA
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):474-485. PubMed ID: 30321616
[TBL] [Abstract][Full Text] [Related]
47. Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
Han Q; Chen R; Wang F; Chen S; Sun X; Guan X; Yang Y; Peng B; Pan X; Li J; Yi W; Li P; Zhang H; Feng D; Chen A; Li X; Li S; Yin Z
PLoS One; 2018; 13(4):e0192888. PubMed ID: 29617363
[TBL] [Abstract][Full Text] [Related]
48. Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents.
Nushtaeva AA; Stepanov GA; Semenov DV; Juravlev ES; Balahonova EA; Gerasimov AV; Sidorov SV; Savelyev EI; Kuligina EV; Richter VA; Koval OA
BMC Cancer; 2018 Jul; 18(1):728. PubMed ID: 29986702
[TBL] [Abstract][Full Text] [Related]
49. Expression of
Wang WS; Zi JJ; Sun MT; Mei W; Li SF; Yang N; Fei ZY; Zhang RP; Yu M; Xiong W
Transl Cancer Res; 2020 Jan; 9(1):173-186. PubMed ID: 35117171
[TBL] [Abstract][Full Text] [Related]
50. CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells.
Moradi F; Mohajerani F; Sadeghizadeh M
Life Sci; 2022 Dec; 311(Pt B):121183. PubMed ID: 36375570
[TBL] [Abstract][Full Text] [Related]
51. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
[TBL] [Abstract][Full Text] [Related]
52. Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer.
Beaudin SG; Robilotto S; Welsh J
J Steroid Biochem Mol Biol; 2015 Apr; 148():96-102. PubMed ID: 25239595
[TBL] [Abstract][Full Text] [Related]
53. RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway.
Lyu JH; Park DW; Huang B; Kang SH; Lee SJ; Lee C; Bae YS; Lee JG; Baek SH
J Cell Biochem; 2015 Feb; 116(2):260-7. PubMed ID: 25187114
[TBL] [Abstract][Full Text] [Related]
54. Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.
Kähkönen TE; Toriseva M; Petruk N; Virta AR; Maher A; Eigéliené N; Kaivola J; Boström P; Koskivuo I; Nees M; Tuomela JM; Ivaska KK; Härkönen PL
Cell Oncol (Dordr); 2021 Feb; 44(1):205-218. PubMed ID: 33119860
[TBL] [Abstract][Full Text] [Related]
55. Amplification of nuclear deformation of breast cancer cells by seeding on micropatterned surfaces to better distinguish their malignancies.
Antmen E; Demirci U; Hasirci V
Colloids Surf B Biointerfaces; 2019 Nov; 183():110402. PubMed ID: 31398621
[TBL] [Abstract][Full Text] [Related]
56. Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3'-diindolylmethene in human breast epithelial cell lines.
Licznerska BE; Szaefer H; Murias M; Bartoszek A; Baer-Dubowska W
Eur J Nutr; 2013 Aug; 52(5):1483-92. PubMed ID: 23090135
[TBL] [Abstract][Full Text] [Related]
57. Short-term exposure to ethanol induces transcriptional changes in nontumorigenic breast cells.
Miller GM; Brant TS; Goodrich JA; Kugel JF
FEBS Open Bio; 2023 Oct; 13(10):1941-1952. PubMed ID: 37572351
[TBL] [Abstract][Full Text] [Related]
58. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
[TBL] [Abstract][Full Text] [Related]
59. Label-free, microfluidic separation and enrichment of human breast cancer cells by adhesion difference.
Kwon KW; Choi SS; Lee SH; Kim B; Lee SN; Park MC; Kim P; Hwang SY; Suh KY
Lab Chip; 2007 Nov; 7(11):1461-8. PubMed ID: 17960272
[TBL] [Abstract][Full Text] [Related]
60. Is the regulation by miRNAs of NTPDase1 and ecto-5'-nucleotidase genes involved with the different profiles of breast cancer subtypes?
da Silva FC; de Melo Neto AB; Martins CA; de Sousa Cardoso TC; de Souza Gomes M; de Araújo TG; Fürstenau CR
Purinergic Signal; 2022 Mar; 18(1):123-133. PubMed ID: 34741235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
